US20100100166A1 - Longitudinally flexible stent - Google Patents
Longitudinally flexible stent Download PDFInfo
- Publication number
- US20100100166A1 US20100100166A1 US12/644,688 US64468809A US2010100166A1 US 20100100166 A1 US20100100166 A1 US 20100100166A1 US 64468809 A US64468809 A US 64468809A US 2010100166 A1 US2010100166 A1 US 2010100166A1
- Authority
- US
- United States
- Prior art keywords
- stent
- loop containing
- containing section
- loops
- loop
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91508—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a difference in amplitude along the band
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91525—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0054—V-shaped
Definitions
- the present invention relates generally to stents, which are endoprostheses implanted into vessels within the body, such as blood vessels, to support and hold open the vessels, or to secure and support other endoprostheses in the vessels.
- the present invention relates to a stent which is longitudinally flexible before and after expansion.
- stents are known in the art.
- stents are generally tubular in shape, and are expandable from a relatively small, unexpanded diameter to a larger, expanded diameter.
- the stent is typically mounted on the end of a catheter, with the stent being held on the catheter at its relatively small, unexpanded diameter.
- the unexpanded stent is directed through the lumen to the intended implantation site.
- the stent is expanded, typically either by an internal force, for example by inflating a balloon on the inside of the stent, or by allowing the stent to self-expand, for example by removing a sleeve from around a self-expanding stent, allowing the stent to expand outwardly.
- the expanded stent resists the tendency of the vessel to narrow, thereby maintaining the vessel's patency.
- U.S. Pat. No. 5,733,303 to Israel et al. (“'303”), which is expressly incorporated by reference, shows a unique stent formed of a tube having a patterned shape which has first and second meander patterns having axes extending in first and second directions.
- the second meander patterns are intertwined with the first meander patterns to form flexible cells.
- Stents such as this one are very flexible in their unexpanded state such that they can be tracked easily down tortuous lumens. Upon expansion, these stents provide excellent radial support, stability, and coverage of the vessel wall. These stents are also conformable, in that they adapt to the shape of the vessel wall during implantation.
- FIG. 1 a schematic diagram of a conventional stent 202 in a curved vessel 204 .
- a stent To implant a stent, it maybe delivered to a desired site by a balloon catheter when the stent is in an unexpanded state.
- the balloon catheter is then inflated to expand the stent, affixing the stent into place. Due to the high inflation pressures of the balloon—up to 20 atm—the balloon causes the curved vessel 204 and even a longitudinally flexible stent to straighten when it is inflated. If the stent, because of the configuration of its mesh is or becomes relatively rigid after expansion, then the stent remains or tends to remain in the same or substantially the same shape after deflation of the balloon. However, the artery attempts to return to its natural curve (indicated by dashed lines)in FIG. 1 with reference to a conventional mesh stent.
- the mismatch between the natural curve of the artery and the straightened section of the artery with a stent may cause points of stress concentration 206 at the ends of the stent and stress along the entire stent length.
- the coronary vasculature can impose additional stress on stents because the coronary vasculature moves relatively significant amounts with each heartbeat. For illustration purposes, the difference between the curve of the vessel and the straightened stent has been exaggerated in FIG. 1 .
- U.S. Pat. No. 5,807,404 to Richter which is expressly incorporated by reference, shows another stent which is especially suited for implantation into curved arterial portions or osteal regions.
- This stent can include sections adjacent the end of the stent with greater bending flexibility than the remaining axial length of the stent. While this modification at the end of the stent alleviates the stress at the end points, it does not eliminate the stress along the entire length of the stent.
- U.S. Pat. Nos. 4,886,062 and 5,133,732 to Wiktor (“the Wiktor '062 and '732 patents”) show various stents formed of wire wherein the wire is initially formed into a band of zig-zags forming a serpentine pattern, and then the zig-zag band is coiled into a helical stent.
- the stents are expanded by an internal force, for example by inflating a balloon.
- the coiled zig-zag stents that are illustrated in FIGS. 1 through 6 of the Wiktor '062 and '732 patents are longitudinally flexible both in the expanded and unexpanded condition such that they can be tracked easily down tortuous lumens and such that they conform relatively closely to the compliance of the vessel after deployment. While these stents are flexible, they also have relatively unstable support after expansion. Furthermore, these stents leave large portions of the vessel wall uncovered, allowing tissue and plaque prolapse into the lumen of the vessel.
- a stent which exhibits longitudinal flexibility before expansion such that it can easily be tracked down tortuous lumens and longitudinal flexibility after expansion such that it can comply with the vessel's natural flexibility and curvature while still providing continuous, stable coverage of a vessel wall that will minimize tissue sag into the lumen.
- an object of the invention is to provide a stent that is longitudinally flexible before expansion so that it can easily be tracked down tortuous vessels and remains longitudinally flexible after expansion such that it will substantially eliminate any stress points by complying with the vessel's flexibility and assuming the natural curve of the vessel.
- Another object of the present invention is to provide a stent that is longitudinally flexible after delivery such that it flexes during the cycles of the heartbeat to reduce cyclic stress at the ends of the stent and along the stent.
- Another object of the present invention is to provide a stent with a closed cell pattern such that it provides good coverage and support to a vessel wall after expansion.
- the stent of the present invention is formed to be a tube having a patterned shape which has first and second meander patterns having axes extending in first and second direction wherein the second meander patterns are intertwined with the first meander patterns.
- the intertwined meander patterns form cells which have three points at which the first and second meander patterns meet each other, and which in this sense could be called triangular cells.
- These three cornered or triangular cells are flexible about the longitudinal axis of the stent after expansion.
- These triangular cells provide comparable scaffolding and radial strength to that of cells formed by intertwined meander patterns which have four points at which the first and second patterns meet each other, and which in this sense could be called square cells.
- bands of cells are provided along the length of a stent.
- the bands of cells alternate between cells adapted predominantly to enhance radial support with cells that are adapted predominantly to enhance longitudinal flexibility after expansion.
- the first meander patterns are adapted to prevent any “flaring out” of loops of the first meander patterns during delivery of the stent.
- a stent according to the invention retains the longitudinal flexibility associated with the '303 cellular stent in its unexpanded state, and has increased longitudinal flexibility in the expanded state.
- the stent does so without sacrificing scaffolding—i.e. coverage of the vessel wall—or radial support.
- cells formed by the meander patterns are such that, when the expanded stent is bent while inside a lumen, the cells on the outside of the curve open in length, but narrow in width whereas the cells on the inside of the curve shorten in length but thicken in width so that the area of the cell, and the density of the struts, remains much more constant than otherwise.
- the stent is coated with a medicine, a more even dose is applied to the inside wall of the lumen, avoiding the possibility that a toxic dose be supplied at one area while a less than effective dose is applied to another area.
- FIG. 1 shows a schematic diagram of a conventional rigid stent deployed in a curved lumen.
- FIG. 2 shows a schematic diagram of a stent of the present invention deployed in a curved lumen.
- FIG. 3 shows a pattern for a stent made in accordance with the present invention.
- FIG. 4 shows an enlarged view of one cell of the pattern of FIG. 3 .
- FIG. 5 shows a pattern for a stent made in accordance with the present invention
- FIG. 6 shows an enlarged view of one cell of the pattern of FIG. 5 .
- FIG. 7 shows a pattern for a stent made in accordance with the present invention.
- FIG. 8 shows an enlarged view of one cell used in the pattern of FIG. 7 .
- FIG. 9 shows an enlarged view of another cell used in FIG. 7 .
- FIG. 10 shows a schematic comparison of a four cornered or “square cell” and a three cornered or “triangular” cell of the present invention.
- FIG. 11 shows a pattern for a stent constructed according to the principles of the invention which has variable geometry along its length.
- FIG. 12 shows another pattern for a stent constructed according to the principles of the invention.
- FIG. 13 shows another pattern for a stent constructed according to the principles of the invention.
- FIG. 14 shows the expansion of a portion of a horizontal meander pattern built according to the principles of the invention.
- FIG. 15 shows a view of the shape of single cell on the outside of a curve superimposed on the same cell on the inside of a curve.
- FIG. 2 shows a schematic diagram of a longitudinally flexible stent 208 of the present invention.
- the stent 208 may be delivered to a curved vessel 210 by a balloon catheter, and implanted in the artery by inflating the balloon.
- the balloon causes the artery to straighten upon inflation of the balloon.
- the stent 208 assumes the natural curve of the vessel 210 because it is and remains longitudinally flexible after expansion. This reduces any potential stress points at the ends of the stent and along the length of the stent.
- the stent is longitudinally flexible after expansion, the stent will flex longitudinally with the vessel during the cycles caused by a heartbeat. This also reduces any cyclic stress at the ends of the stent and along the length of the stent.
- FIG. 3 shows a pattern of a stent according to the present invention.
- This pattern may be constructed of known materials, and for example stainless steel, but it is particularly suitable to be constructed from NiTi.
- the pattern can be formed by etching a flat sheet of NiTi into the pattern shown.
- the flat sheet is formed into a stent by rolling the etched sheet into a tubular shape, and welding the edges of the sheet together to form a tubular stent.
- the details of this method of forming the stent which has certain advantages, are disclosed in U.S. Pat. Nos. 5,836,964 and 5,997,973, which are hereby expressly incorporated by reference.
- NiTi stent is heat treated, as known by those skilled in the art, to take advantage of the shape memory characteristics of NiTi and its superelasticity.
- the pattern 300 is formed from a plurality of each of two orthogonal meander patterns which patterns are intertwined with each other.
- the term “meander pattern” is taken herein to describe a periodic pattern about a center line and “orthogonal meander patterns” are patterns whose center lines are orthogonal to each other.
- a meander pattern 301 is a vertical sinusoid having a vertical center line 302 . It will be recognized that this is not a perfect sinusoid, but only an approximation thereof. Thus, as used herein, the term sinusoid refers to a periodic pattern which varies positively and negatively symmetrically about an axis; it need not be an exact sine function.
- a meander pattern 301 has two loops 304 and 306 per period wherein loops 304 open to the right while loops 306 open to the left. Loops 304 and 306 share common members 308 and 310 , where member 308 joins one loop 304 to its following loop 306 and member 308 joins one loop 306 to its following loop 304 .
- the vertical sinusoid of meander pattern 301 has a first frequency.
- a meander pattern 312 (two of which have been shaded for reference) is a horizontal pattern having a horizontal center line 314 .
- a horizontal meander pattern 312 also has loops labeled 316 , 318 , 320 , 322 , and between the loops of a period is a section labeled 324 .
- these loops are part of a vertical sinusoid 303 which has a higher frequency than that of the meander patterns 301 .
- Vertical sinusoids 301 alternate with vertical sinusoids 303 .
- Vertical sinusoids 303 have a second frequency higher than the first frequency of the vertical meander patterns, i.e., sinusoids 301 .
- each left opening loop 306 of meander pattern 3010 faces a right opening loop 304 of meander pattern 301 e and a right opening loop 304 of meander pattern 3010 faces a left opening loop 306 of meander pattern 301 e.
- the horizontal meander pattern 312 is also provided in odd and even forms.
- the straight sections 324 of the horizontal meander pattern 312 e intersect with every third common member 310 of the even vertical meander pattern 301 e.
- the straight sections 324 of the horizontal meander pattern 3120 also intersect with every third common member 310 of the odd vertical meander pattern 301 .
- alternating sinusoids 303 are intermittently coupled to the meander patterns 301 . For example, between points 315 and 317 , where vertical pattern 303 is coupled to vertical pattern 301 e, there are two loops 306 and one loop 304 of vertical pattern 301 e and three loops 319 and two loops 321 of vertical pattern 303 .
- this embodiment of the stent is made of NiTi, and it is reboundable, it typically will be self-expanding.
- the loops of the vertical meander patterns 301 open up in the vertical direction. This causes them to shorten in the horizontal direction.
- the loops in the horizontal meander pattern 312 open up both in the vertical direction and the horizontal direction, compensating for the shortening of the loops of the vertical meander patterns.
- the loops of the horizontal meander pattern 312 which are the loops of the vertical pattern 303 in the present invention avoids foreshortening in a self-expanding stent in a particularly effective manner.
- a self-expanding stent formed of a shape-memory alloy must be compressed from an expanded position to a compressed position for delivery.
- the length 606 of the horizontal meander pattern (width of the vertical pattern 330 ) naturally shrinks.
- a stent formed from the pattern of FIG. 3 and made of NiTi is particularly well suited for use in the carotid artery or other lumens subject to an outside pressure.
- One reason is that because the stent is formed of NiTi, it is reboundable, which is a desirable property for stents placed in the carotid artery.
- the other reason is that the stent of FIG. 3 offers excellent scaffolding, which is particularly important in the carotid artery. Scaffolding is especially important in the carotid artery because dislodged particles in the artery may embolize and cause a stroke.
- FIG. 4 is an expanded view of one flexible cell 500 of the pattern of FIG. 3 .
- Each flexible cell 500 includes: a first member 501 having a first end 502 and a second end 503 ; a second member 504 having a first end 505 and a second end 506 ; a third member 507 having a first end 508 and a second end 509 ; and a fourth member 510 having a first end 511 and a second end 512 .
- the first end 502 of the first member 501 is joined to the first end 505 of the second member 504 by a first curved member 535 to form a first loop 550
- the second end 506 of the second member 504 is joined to the second end 509 of the third member 508 by a second curved member 536
- the first end 508 of the third member 507 is joined to the first end 511 of the fourth member 510 by a third curved member 537 to form a second loop 531
- the first loop 550 defines a first angle 543 .
- the second loop 531 defines a second angle 544 .
- Each cell 500 also includes a fifth member 513 having a first end 514 and a second end 515 ; a sixth member 516 having a first end 517 and a second end 518 ; a seventh member 519 having a first end 520 and a second end 521 ; an eighth member 522 having a first end 523 and a second end 524 ; a ninth member 525 having a first end 526 and a second end 527 ; and a tenth member 528 having a first end 529 and a second end 530 .
- the first end 514 of the fifth member 513 is joined to the second end 503 of the first member 501 at second junction point 542
- the second end 515 of the fifth member 513 is joined to the second end 518 of the sixth member by a curved member 539 to form a third loop 532
- the first end 517 of the sixth member 516 is joined to the first end 520 of the seventh member 519 by a fifth curved member 548
- the second end 521 of the seventh member 519 is joined to the second end 524 of the eighth member 522 at third junction point 540 to form a fourth loop 533
- the first end 523 of the eighth member 522 is joined to the first end 526 of the ninth member 525 by a sixth curved member 549
- the second end 526 of the ninth member 525 is joined to the second end 530 of the tenth member 528 by a seventh curved member 541 to form a fifth loop 534
- the first end 529 of the tenth member 528 is joined to the second end 512
- the first member 501 , the third member 507 , the sixth member 516 , the eighth member 522 , and the tenth member 528 have substantially the same angular orientation to the longitudinal axis of the stent and the second member 504 , the fourth member 510 , the fifth member 513 , the seventh member 519 , and the ninth member 512 have substantially the same angular orientation to the longitudinal axis of the stent.
- the lengths of the first, second, third and fourth members 501 , 504 , 507 , 510 are substantially equal.
- each cell includes two cycles of the lower frequency vertical pattern and three cycles of the higher frequency vertical pattern.
- the first, second, third, and fourth members 501 , 504 , 507 , 510 may have a width that is greater than the width of the fifth, sixth, seventh, eighth, ninth, and tenth members 513 , 516 , 519 , 522 , 525 , 528 in that cell.
- the differing widths of the first, second, third, and fourth members and the fifth, sixth, seventh, eighth, ninth, and tenth members with respect to each other contribute to the overall flexibility and resistance to radial compression of the cell.
- the widths of the various members can be tailored for specific applications. For example, the ratio of width maybe approximately 50-70%.
- the fifth, sixth, seventh, eighth, ninth, and tenth members may be optimized predominantly to enable longitudinal flexibility, both before and after expansion, while the first, second, third, and fourth members may be optimized predominantly to enable sufficient resistance to radial compression to hold a vessel open.
- specific members may be optimized to predominantly enable a desired characteristic, all the portions of the cell interactively cooperate and contribute to the characteristics of the stent.
- FIGS. 5 and 6 show a pattern and an expanded view of one cell of an embodiment of the present invention which is specially adapted for a stent made of stainless steel.
- the pattern is similar to the pattern of FIGS. 3 and 4 , and the same reference numerals are used to indicate the generally corresponding parts.
- the stents of the embodiment of FIGS. 5 and 6 will normally be expanded by a balloon, in conventional fashion.
- FIGS. 3 and 5 can also be viewed as being made up of high frequency and low frequency vertical sinusoidal patterns or vertical loop containing sections which are arranged generally in the circumferential direction and which are periodically interconnected.
- first loop containing section with loops occurring at a first frequency extending along line 301 and a second loop containing section with also occurring at said first frequency extending along line 302 .
- a third loop containing section 303 extending along line 305 has loops occurring at a second frequency that is higher than said first frequency. It is disposed between the first and second loop containing sections and alternately joined to the first and second loop containing sections.
- the high frequency is in a ratio of 3/2 to the low frequency.
- the higher frequency loop containing elements are smaller in width. The relative widths can be selected so that the high frequency elements are crimpable to the same diameter as the lower frequency elements.
- the high frequency vertical patterns of smaller width result in elements having a lower maximal strain.
- the lower maximal strain is below the maximum strain without non-elastic deformation for the material of the stent.
- the lower maximal strain is below approximately 0.4%, even for a 1500 bend, as confirmed by finite element analysis.
- a '303 type stent for an equivalent amount of bending, exhibits a maximum strain of 8%.
- the strain during heart beat happens 8,000,000 times every year and cannot be much above elastic limit without the stent breaking Since, embodiments of the present invention keep the strain below the limit means that the stent of the present invention can bend with the lumen as the heart beats, for many years without breaking.
- the second loops 531 are made stronger by shortening the third and fourth members 507 , 510 . This helps assure that the second loops do not “flare out” during delivery of the stent through tortuous anatomy. This “flaring out” is not a concern with NiTi stents which are covered by a sheath during delivery.
- the length of the members in this embodiment may be shorter than the length of the corresponding members in the embodiment illustrated in FIGS. 3 and 4 .
- the amount of strain allowed in a self-expanding NiTi stent may be around 10%.
- the amount of strain allowed during the plastic deformation which take place, for example, during expansion typically may be 20% or greater. Therefore, to facilitate stents made of NiTi and stents made of stainless steel expanding to comparable diameters, the members of the NiTi stent may be longer than the members of a stainless steel stent.
- the stent When the stent is within a curved lumen when it is expanded, the stent is curved as shown in FIG. 2
- the result of this curving, for a single cell 500 is shown in FIG. 15 .
- the cells on the outside of the curve open in length, but narrow in width whereas the cells on the inside of the curve shorten in length but thicken in width.
- the density of the members per unit of surface area remains closer to what it is in an uncurved, expanded condition, both on the inside and outside of the curve.
- the area of the cell remains more constant than it would without compensation.
- the ratio between a toxic dose and an effective dose may be smaller than 10:1.
- the cell will open up increasing the length of the cell.
- the adjoining struts will come closer to each other, to cause the cell to become narrower in width, or in the circumferential direction, compensating for the increase in length.
- the longitudinal distances must decrease. Again, it is easy to see that the compression which occurs on the inside results in the struts on either side of the junction points 542 and 538 being squeezed closed and the width of the cell decreasing.
- the struts will move further apart from each other and the cell becomes more narrow in length but thicker in width again providing compensation.
- the increase in one direction is compensated in the other direction to make the area more constant than it would have been without the compensation.
- FIG. 7 illustrates another aspect of the present invention.
- the stent of FIG. 7 is also constructed from orthogonal meander patterns 301 , 302 .
- the meander patterns form a series of interlocking cells 50 , 700 of two types.
- the first type of cell 50 is taught by U.S. Pat. No. 5,733,303. These cells are arranged so that they form alternating bands 704 of first type of cells 50 and bands 706 of the second type of cells 700 .
- each of the '303 cells 50 has a first longitudinal apex 100 and a second longitudinal end 78 .
- Each cell 50 also is provided with a first longitudinal end 77 and a second longitudinal apex 104 disposed at the second longitudinal end 78 .
- Each cell 50 also includes a first member 51 having a longitudinal component having a first end 52 and a second end 53 ; a second member 54 having a longitudinal component having a first end 55 and a second end 56 ; a third member 57 having a longitudinal component having a first end 58 and a second end 59 ; and a fourth member 60 having a longitudinal component having a first end 61 and a second end 62 .
- the stent also includes a first loop or curved member 63 defining a first angle 64 disposed between the first end 52 of the first member 51 and the first end 55 of the second member 54 .
- a second loop or curved member 65 defining a second angle 66 is disposed between the second end 59 of the third member 57 and the second end 62 of the fourth member 60 and is disposed generally opposite to the first loop 63 .
- a first flexible compensating member (or a section of a longitudinal meander pattern) 67 having curved portion and two legs with a first end 68 and a second end 69 is disposed between the first member 51 and the third member 57 with the first end 68 of the first flexible compensating member 67 joined to and communicating with the second end 53 of the first member 51 and the second end 69 of the first flexible compensating member 67 joined to and communicating with the first end 58 of the third member 57 .
- the first end 68 and the second end 69 are disposed a variable longitudinal distance 70 from each other.
- a second flexible compensating member (or, a section of a longitudinal meander pattern) 71 having a first end 72 and a second end 73 is disposed between the second member 54 and the fourth member 60 .
- the first end 72 of the second flexible compensating member 71 is joined to and communicates with the second end 56 of the second member 54 and the second end 73 of the second flexible compensating member 71 is joined to and communicates with the first end 61 of the fourth member 60 .
- the first end 72 and the second end 73 are disposed a variable longitudinal distance 74 from each other.
- the first and second flexible compensating members, and particularly the curved portion thereof, 67 and 71 are arcuate.
- the flexible connecting members 67 and 71 will open up increasing the distances 70 and 74 .
- the members 57 and 60 will come closer to each other, as will members 51 and 54 . This will further lengthen the cell. But at the same time it will become narrower in width, or in the circumferential direction to compensate for the opening up of the flexible connector members 67 and 71 .
- the longitudinal distances must decrease. Again, if is easy to see that the compression which occurs on the inside results in the loops 67 and 71 being squeezed closed and the distances 70 and 74 decreasing.
- the members 57 and 60 and members 51 and 54 will move further apart from each other and the longitudinal components of members 57 , 60 , 51 and 54 will decrease.
- the cell becomes narrower in length but thicker in width.
- the increase in one direction is compensated in the other direction to make the area more constant than it would have been without the compensation.
- each flexible compensating member 67 , 71 includes: a first portion or leg 79 with a first end 80 and a second end 81 ; a second portion or leg 82 with a first end 83 and a second end 84 ; and a third portion or leg 85 with the first end 86 and a second end 87 , with the second end 81 and the second end 84 being joined by a curved member and the first end 83 and the first end 86 being joined by a curved member.
- the first end of a flexible compensating member 67 , 71 is the same as the first end 80 of the first portion 79
- the second end of a flexible compensating member 67 , 71 is the same as the second end 87 of the third portion 85 .
- a first area of inflection 88 is disposed between the second end 81 of the first portion 79 and the second end 84 of the second portion 82 where the curved portion joining them lies.
- a second area of inflection 89 is disposed between the first end 83 of the second portion 82 and the first end 86 of the third portion 85 where the curved portion joining them lies.
- FIG. 7 illustrates a pattern of alternating bands of cells
- the stent may be optimized for a particular usage by tailoring the configuration of the bands.
- the middle band of the second type of cells 700 may instead be formed of cells 50 , or vice versa.
- the second type of cells in FIG. 7 may also utilize the cell configurations described with respect to FIGS. 4 and 6 .
- the cell configurations of FIGS. 4 and 6 provide the advantage that they will not cause any torque of one portion of the cell relative to another portion of the cell about the longitudinal axis of the stent upon expansion, which may happen when the second type of cells 700 expand, a torque which could cause a stent to deform, and stick out.
- all of the flexible compensating members are arranged so that the path of the flexible compensating members, from left to right, travels in a generally downward direction.
- the cells 700 can also be arranged so that the flexible compensating members in one band are arranged in a generally upward direction, and the flexible compensating members in an adjacent band are arranged in a generally downward direction.
- One skilled in the art can easily make these modifications.
- FIG. 10 is a schematic representation comparing the cells 804 of the present invention, which have three points where the intertwined first and second meander patterns meet and are in that sense three cornered or triangular cells, with cells 802 of the '303 stent which have four points where the intertwined first and second meander patterns meet and are in that sense four cornered or square cells. More particularly, on the left side of FIG. 10 , a pair of vertical meander patterns 806 , 826 are joined by members 808 , 810 , 812 (which are sections of longitudinal meander patterns) to form a plurality of three cornered or triangular cells 804 . By triangular cell, it is meant. that there are three sections 810 , 812 , 814 , each having loop portions and three associated points 816 , 818 , 820 of their joining, forming each cell.
- a pair of vertical meander patterns 822 , 824 are joined together compensating members 828 , 830 , 832 , 834 (which are sections of a longitudinal meander) to form a plurality of square cells 804 .
- square cell it is meant that there are four sections, each having loop portions, and four associated points of their joining, forming each cell.
- the shaded cell 802 is formed from four sections 832 , 836 , 830 , 838 , with four associated points of their joining 840 , 842 , 844 , 846 .
- Both the square cell and the triangular cell have two kinds of sections with loops.
- the first kind of loop containing section is formed from a vertical meander pattern and is optimized predominantly to enable radial support.
- the second kind of loop containing section is optimized predominantly to enable flexibility along the longitudinal axis of the stent.
- each loop containing section is optimized predominantly to enable a desired characteristic of the stent, the sections are interconnected and cooperate to define the characteristics of the stent. Therefore, the first kind of loop containing section contributes to the longitudinal flexibility of the stent, and the second kind of loop containing section contributes to the radial support of the stent.
- the second kind of loop containing sections 830 , 832 each have one inflection point 848 , 850 .
- the loop containing sections 810 , 812 each have two inflection point areas 852 , 854 , 856 , 858 .
- the higher number of inflection points allows more freedom to deform after expansion of the stent and distributes the deformation over a longer section, thus, reducing the maximal strain along these loop containing sections.
- a square cell 802 is generally more elongated along the longitudinal axis of the stent than a triangular cell 804 , which is generally more elongated along the circumference of the stent. This also contributes to higher flexibility after expansion.
- the area of a triangular cell 804 is the same as a square cell 802 .
- a triangular cell offers increased coverage of a vessel wall.
- the stent is substantially uniform over its entire length.
- a band of cells 850 may be designed to provide different flexibility characteristics or different radial compression characteristics than the remaining bands of cells by altering the widths and lengths of the members making up that band.
- the stent may be adapted to provide increased access to a side branch lumen by providing at least one cell 852 which is larger in size then the remaining cells, or by providing an entire band of cells 854 which are larger in size than the other bands of cells.
- the stent may be designed to expand to different diameters along the length of the stent.
- the stent may also be treated after formation of the stent by coating the stent with a medicine, plating the stent with a protective material, plating the stent with a radiopaque material, or covering the stent with a material.
- FIGS. 12 and 13 show alternative patterns for a stent constructed according to the principles of the present invention.
- the stent shown in FIG. 12 has two bands of cells 856 located at each of the proximal end 860 and distal and 862 .
- the cells that form the bands of cells 856 located at the ends of the stent are '303 type cells.
- the remaining cells in the stent are the same as described with respect to the cells 500 depicted in FIG. 6 .
- the stent shown in FIG. 13 has alternating bands of cells 864 , 866 , 868 .
- the first type of band of cells 864 is composed of '303 type cells.
- the second and third types of bands of cells 866 , 868 are formed of the cells described with respect to the cells 500 depicted in FIG. 4 .
- any various combination of cells may be used in the present invention.
- a longitudinally flexible stent that utilizes a closed cell structure to provide excellent coverage of the vessel wall.
- the general concepts described herein can be utilized to form stents with different configurations than the particular embodiments described herein.
- the general concepts can be used to form bifurcated stents. It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described above. Rather, the scope of the present invention is defined by the claims which follow.
Abstract
An intravascular stent especially suited for implanting in curved arterial portions. The stent retains longitudinal flexibility after expansion. The stent is formed of intertwined meander patterns forming triangular cells. The triangular cells are adapted to provide radial support, and also to provide longitudinal flexibility after expansion. The triangular cells provide increased coverage of a vessel wall. The stent can have different portions adapted to optimize radial support or to optimize longitudinal flexibility. Loops in the stent are disposed and adapted to cooperate so that after expansion of said stent within a curved lumen, the stent is curved and cells on the outside of the curve open in length, but narrow in width whereas cells on the inside of the curve shorten in length but thicken in width to maintain a density of stent element area which much more constant than otherwise between the inside and the outside of the curve. As a result, when the stent is coated with a medicine the more constant density of stent elements results in an even dose being applied to the inside wall of the lumen, avoiding the possibility that a toxic dose be supplied at one area while a less than effective dose is applied to another area.
Description
- This application is a continuation of Ser. No. 09/864,389 filed May 25, 2001, which is a continuation-in-part of Ser. No. 09/795,794, now U.S. Pat. No. 6,709,453, filed Feb. 28, 2001, which is a continuation-in-part of Ser. No. 09/516,753 filed Mar. 1, 2000, now U.S. Pat. No. 7,141,062, and which also claims the priority of
Provisional Application 60/202,723, filed May 8, 2000. - The present invention relates generally to stents, which are endoprostheses implanted into vessels within the body, such as blood vessels, to support and hold open the vessels, or to secure and support other endoprostheses in the vessels. In particular, the present invention relates to a stent which is longitudinally flexible before and after expansion.
- Various stents are known in the art. Typically stents are generally tubular in shape, and are expandable from a relatively small, unexpanded diameter to a larger, expanded diameter. For implantation, the stent is typically mounted on the end of a catheter, with the stent being held on the catheter at its relatively small, unexpanded diameter. By the catheter, the unexpanded stent is directed through the lumen to the intended implantation site. Once the stent is at the intended implantation site, it is expanded, typically either by an internal force, for example by inflating a balloon on the inside of the stent, or by allowing the stent to self-expand, for example by removing a sleeve from around a self-expanding stent, allowing the stent to expand outwardly. In either case, the expanded stent resists the tendency of the vessel to narrow, thereby maintaining the vessel's patency.
- U.S. Pat. No. 5,733,303 to Israel et al. (“'303”), which is expressly incorporated by reference, shows a unique stent formed of a tube having a patterned shape which has first and second meander patterns having axes extending in first and second directions. The second meander patterns are intertwined with the first meander patterns to form flexible cells. Stents such as this one are very flexible in their unexpanded state such that they can be tracked easily down tortuous lumens. Upon expansion, these stents provide excellent radial support, stability, and coverage of the vessel wall. These stents are also conformable, in that they adapt to the shape of the vessel wall during implantation. It is readily apparent that, by nature, when the stent shown, for example, in
FIG. 8 thereof is expanded in a curved lumen, cells on the outside of the curve open in length, but narrow in width whereas cells on the inside of the curve shorten in length but thicken in width to maintain a density of stent element area which much more constant than otherwise between the inside and the outside of the curve. - One feature of stents with a cellular mesh design such as this one, however, is that they have limited longitudinal flexibility after expansion, which may be a disadvantage in particular applications. This limited longitudinal flexibility may cause stress points at the end of the stent and along the length of the stent. Conventional mesh stents like that shown in U.S. Pat. No. 4,733,665 may simply lack longitudinal flexibility, which is illustrated by
FIG. 1 , a schematic diagram of aconventional stent 202 in acurved vessel 204. - To implant a stent, it maybe delivered to a desired site by a balloon catheter when the stent is in an unexpanded state. The balloon catheter is then inflated to expand the stent, affixing the stent into place. Due to the high inflation pressures of the balloon—up to 20 atm—the balloon causes the
curved vessel 204 and even a longitudinally flexible stent to straighten when it is inflated. If the stent, because of the configuration of its mesh is or becomes relatively rigid after expansion, then the stent remains or tends to remain in the same or substantially the same shape after deflation of the balloon. However, the artery attempts to return to its natural curve (indicated by dashed lines)inFIG. 1 with reference to a conventional mesh stent. The mismatch between the natural curve of the artery and the straightened section of the artery with a stent may cause points ofstress concentration 206 at the ends of the stent and stress along the entire stent length. The coronary vasculature can impose additional stress on stents because the coronary vasculature moves relatively significant amounts with each heartbeat. For illustration purposes, the difference between the curve of the vessel and the straightened stent has been exaggerated inFIG. 1 . - U.S. Pat. No. 5,807,404 to Richter, which is expressly incorporated by reference, shows another stent which is especially suited for implantation into curved arterial portions or osteal regions. This stent can include sections adjacent the end of the stent with greater bending flexibility than the remaining axial length of the stent. While this modification at the end of the stent alleviates the stress at the end points, it does not eliminate the stress along the entire length of the stent.
- Various stents are known that retain longitudinal flexibility after expansion. For example, U.S. Pat. Nos. 4,886,062 and 5,133,732 to Wiktor (“the Wiktor '062 and '732 patents”) show various stents formed of wire wherein the wire is initially formed into a band of zig-zags forming a serpentine pattern, and then the zig-zag band is coiled into a helical stent. The stents are expanded by an internal force, for example by inflating a balloon.
- The coiled zig-zag stents that are illustrated in
FIGS. 1 through 6 of the Wiktor '062 and '732 patents are longitudinally flexible both in the expanded and unexpanded condition such that they can be tracked easily down tortuous lumens and such that they conform relatively closely to the compliance of the vessel after deployment. While these stents are flexible, they also have relatively unstable support after expansion. Furthermore, these stents leave large portions of the vessel wall uncovered, allowing tissue and plaque prolapse into the lumen of the vessel. - Thus, it is desired to have a stent which exhibits longitudinal flexibility before expansion such that it can easily be tracked down tortuous lumens and longitudinal flexibility after expansion such that it can comply with the vessel's natural flexibility and curvature while still providing continuous, stable coverage of a vessel wall that will minimize tissue sag into the lumen.
- Accordingly, an object of the invention is to provide a stent that is longitudinally flexible before expansion so that it can easily be tracked down tortuous vessels and remains longitudinally flexible after expansion such that it will substantially eliminate any stress points by complying with the vessel's flexibility and assuming the natural curve of the vessel.
- Another object of the present invention is to provide a stent that is longitudinally flexible after delivery such that it flexes during the cycles of the heartbeat to reduce cyclic stress at the ends of the stent and along the stent.
- Another object of the present invention is to provide a stent with a closed cell pattern such that it provides good coverage and support to a vessel wall after expansion.
- Other advantages of the present invention will be apparent to those skilled in the art.
- In accordance with these objects, the stent of the present invention is formed to be a tube having a patterned shape which has first and second meander patterns having axes extending in first and second direction wherein the second meander patterns are intertwined with the first meander patterns.
- In accordance with one embodiment of the invention, the intertwined meander patterns form cells which have three points at which the first and second meander patterns meet each other, and which in this sense could be called triangular cells. These three cornered or triangular cells are flexible about the longitudinal axis of the stent after expansion. These triangular cells provide comparable scaffolding and radial strength to that of cells formed by intertwined meander patterns which have four points at which the first and second patterns meet each other, and which in this sense could be called square cells.
- In another embodiment of the invention, bands of cells are provided along the length of a stent. The bands of cells alternate between cells adapted predominantly to enhance radial support with cells that are adapted predominantly to enhance longitudinal flexibility after expansion.
- In another embodiment of the invention, the first meander patterns are adapted to prevent any “flaring out” of loops of the first meander patterns during delivery of the stent.
- A stent according to the invention retains the longitudinal flexibility associated with the '303 cellular stent in its unexpanded state, and has increased longitudinal flexibility in the expanded state. The stent does so without sacrificing scaffolding—i.e. coverage of the vessel wall—or radial support.
- In this and other embodiments, cells formed by the meander patterns are such that, when the expanded stent is bent while inside a lumen, the cells on the outside of the curve open in length, but narrow in width whereas the cells on the inside of the curve shorten in length but thicken in width so that the area of the cell, and the density of the struts, remains much more constant than otherwise. This results in maintaining a more constant density of stent elements in contact with the lumen, irrespective of location on the inside or outside of a curved section. In turn, when the stent is coated with a medicine, a more even dose is applied to the inside wall of the lumen, avoiding the possibility that a toxic dose be supplied at one area while a less than effective dose is applied to another area.
-
FIG. 1 shows a schematic diagram of a conventional rigid stent deployed in a curved lumen. -
FIG. 2 shows a schematic diagram of a stent of the present invention deployed in a curved lumen. -
FIG. 3 shows a pattern for a stent made in accordance with the present invention. -
FIG. 4 shows an enlarged view of one cell of the pattern ofFIG. 3 . -
FIG. 5 shows a pattern for a stent made in accordance with the present invention; -
FIG. 6 shows an enlarged view of one cell of the pattern ofFIG. 5 . -
FIG. 7 shows a pattern for a stent made in accordance with the present invention. -
FIG. 8 shows an enlarged view of one cell used in the pattern ofFIG. 7 . -
FIG. 9 shows an enlarged view of another cell used inFIG. 7 . -
FIG. 10 shows a schematic comparison of a four cornered or “square cell” and a three cornered or “triangular” cell of the present invention. -
FIG. 11 shows a pattern for a stent constructed according to the principles of the invention which has variable geometry along its length. -
FIG. 12 shows another pattern for a stent constructed according to the principles of the invention. -
FIG. 13 shows another pattern for a stent constructed according to the principles of the invention. -
FIG. 14 shows the expansion of a portion of a horizontal meander pattern built according to the principles of the invention. -
FIG. 15 shows a view of the shape of single cell on the outside of a curve superimposed on the same cell on the inside of a curve. -
FIG. 2 shows a schematic diagram of a longitudinallyflexible stent 208 of the present invention. Thestent 208 may be delivered to acurved vessel 210 by a balloon catheter, and implanted in the artery by inflating the balloon. As described before, the balloon causes the artery to straighten upon inflation of the balloon. However, upon deflation of the balloon, thestent 208 assumes the natural curve of thevessel 210 because it is and remains longitudinally flexible after expansion. This reduces any potential stress points at the ends of the stent and along the length of the stent. Furthermore, because the stent is longitudinally flexible after expansion, the stent will flex longitudinally with the vessel during the cycles caused by a heartbeat. This also reduces any cyclic stress at the ends of the stent and along the length of the stent. -
FIG. 3 shows a pattern of a stent according to the present invention. This pattern may be constructed of known materials, and for example stainless steel, but it is particularly suitable to be constructed from NiTi. The pattern can be formed by etching a flat sheet of NiTi into the pattern shown. The flat sheet is formed into a stent by rolling the etched sheet into a tubular shape, and welding the edges of the sheet together to form a tubular stent. The details of this method of forming the stent, which has certain advantages, are disclosed in U.S. Pat. Nos. 5,836,964 and 5,997,973, which are hereby expressly incorporated by reference. Other methods known to those of skill in the art such as laser cutting a tube or etching a tube may also be used to construct a stent which uses the present invention. After formation into a tubular shape, a NiTi stent is heat treated, as known by those skilled in the art, to take advantage of the shape memory characteristics of NiTi and its superelasticity. - The
pattern 300 is formed from a plurality of each of two orthogonal meander patterns which patterns are intertwined with each other. The term “meander pattern” is taken herein to describe a periodic pattern about a center line and “orthogonal meander patterns” are patterns whose center lines are orthogonal to each other. - A
meander pattern 301 is a vertical sinusoid having avertical center line 302. It will be recognized that this is not a perfect sinusoid, but only an approximation thereof. Thus, as used herein, the term sinusoid refers to a periodic pattern which varies positively and negatively symmetrically about an axis; it need not be an exact sine function. Ameander pattern 301 has twoloops loops 304 open to the right whileloops 306 open to the left.Loops common members member 308 joins oneloop 304 to its followingloop 306 andmember 308 joins oneloop 306 to its followingloop 304. The vertical sinusoid ofmeander pattern 301 has a first frequency. - A meander pattern 312 (two of which have been shaded for reference) is a horizontal pattern having a
horizontal center line 314. Ahorizontal meander pattern 312 also has loops labeled 316, 318, 320, 322, and between the loops of a period is a section labeled 324. Looked at another way, these loops are part of avertical sinusoid 303 which has a higher frequency than that of themeander patterns 301.Vertical sinusoids 301 alternate withvertical sinusoids 303.Vertical sinusoids 303 have a second frequency higher than the first frequency of the vertical meander patterns, i.e., sinusoids 301. -
Vertical meander pattern 301 is provided in odd and even (0 and e) versions which are 1800 out of phase with each other. Thus, eachleft opening loop 306 ofmeander pattern 3010 faces aright opening loop 304 ofmeander pattern 301 e and aright opening loop 304 ofmeander pattern 3010 faces aleft opening loop 306 ofmeander pattern 301 e. - The
horizontal meander pattern 312 is also provided in odd and even forms. Thestraight sections 324 of thehorizontal meander pattern 312 e intersect with every thirdcommon member 310 of the evenvertical meander pattern 301 e. Thestraight sections 324 of thehorizontal meander pattern 3120 also intersect with every thirdcommon member 310 of the oddvertical meander pattern 301. Viewed asvertical sinusoids 303, alternatingsinusoids 303 are intermittently coupled to themeander patterns 301. For example, between points 315 and 317, wherevertical pattern 303 is coupled tovertical pattern 301 e, there are twoloops 306 and oneloop 304 ofvertical pattern 301 e and threeloops 319 and twoloops 321 ofvertical pattern 303. This corresponds to two cycles ofpattern 301 e and 3 cycles ofpattern 303. Similarly, between two points of coupling betweenvertical pattern 3010 andvertical pattern 303 are twoloops 304 and oneloop 306, again making two cycles. There will be threeloops 321 and twoloops 319, again equal to three cycles ofpattern 303. - Since this embodiment of the stent is made of NiTi, and it is reboundable, it typically will be self-expanding. Upon expansion of the stent, the loops of the
vertical meander patterns 301 open up in the vertical direction. This causes them to shorten in the horizontal direction. The loops in thehorizontal meander pattern 312 open up both in the vertical direction and the horizontal direction, compensating for the shortening of the loops of the vertical meander patterns. - It should be noted that the loops of the
horizontal meander pattern 312, which are the loops of thevertical pattern 303 in the present invention avoids foreshortening in a self-expanding stent in a particularly effective manner. A self-expanding stent formed of a shape-memory alloy must be compressed from an expanded position to a compressed position for delivery. As shown inFIG. 7 , because of the configuration of theloops horizontal meander pattern 312, when the stent is compressed from an expandedposition 602 to a compressed position 604, the length 606 of the horizontal meander pattern (width of the vertical pattern 330) naturally shrinks. Consequently, when the stent expands, theloops vertical meander patterns vertical meander patterns compressed position 610, as illustrated inFIG. 14 . - A stent formed from the pattern of
FIG. 3 and made of NiTi is particularly well suited for use in the carotid artery or other lumens subject to an outside pressure. One reason is that because the stent is formed of NiTi, it is reboundable, which is a desirable property for stents placed in the carotid artery. The other reason is that the stent ofFIG. 3 offers excellent scaffolding, which is particularly important in the carotid artery. Scaffolding is especially important in the carotid artery because dislodged particles in the artery may embolize and cause a stroke. -
FIG. 4 is an expanded view of oneflexible cell 500 of the pattern ofFIG. 3 . Eachflexible cell 500 includes: afirst member 501 having afirst end 502 and asecond end 503; asecond member 504 having afirst end 505 and asecond end 506; athird member 507 having afirst end 508 and asecond end 509; and a fourth member 510 having afirst end 511 and asecond end 512. Thefirst end 502 of thefirst member 501 is joined to thefirst end 505 of thesecond member 504 by a firstcurved member 535 to form a first loop 550, thesecond end 506 of thesecond member 504 is joined to thesecond end 509 of thethird member 508 by a secondcurved member 536, and thefirst end 508 of thethird member 507 is joined to thefirst end 511 of the fourth member 510 by a thirdcurved member 537 to form asecond loop 531. The first loop 550 defines afirst angle 543. Thesecond loop 531 defines asecond angle 544. Eachcell 500 also includes afifth member 513 having afirst end 514 and a second end 515; asixth member 516 having afirst end 517 and a second end 518; aseventh member 519 having afirst end 520 and asecond end 521; aneighth member 522 having afirst end 523 and asecond end 524; aninth member 525 having afirst end 526 and asecond end 527; and atenth member 528 having afirst end 529 and asecond end 530. Thefirst end 514 of thefifth member 513 is joined to thesecond end 503 of thefirst member 501 atsecond junction point 542, the second end 515 of thefifth member 513 is joined to the second end 518 of the sixth member by acurved member 539 to form athird loop 532, thefirst end 517 of thesixth member 516 is joined to thefirst end 520 of theseventh member 519 by a fifthcurved member 548, thesecond end 521 of theseventh member 519 is joined to thesecond end 524 of theeighth member 522 atthird junction point 540 to form afourth loop 533, thefirst end 523 of theeighth member 522 is joined to thefirst end 526 of theninth member 525 by a sixthcurved member 549, thesecond end 526 of theninth member 525 is joined to thesecond end 530 of thetenth member 528 by a seventhcurved member 541 to form afifth loop 534, and thefirst end 529 of thetenth member 528 is joined to thesecond end 512 of the fourth member 510 atfourth junction point 538. Thethird loop 532 defines athird angle 545. Thefourth loop 533 defines afourth angle 546. Thefifth loop 534 defines afifth angle 547. - In the embodiment shown in
FIG. 4 , thefirst member 501, thethird member 507, thesixth member 516, theeighth member 522, and thetenth member 528 have substantially the same angular orientation to the longitudinal axis of the stent and thesecond member 504, the fourth member 510, thefifth member 513, theseventh member 519, and theninth member 512 have substantially the same angular orientation to the longitudinal axis of the stent. In the embodiment shown inFIG. 4 , the lengths of the first, second, third andfourth members tenth members - The first, second, third, and
fourth members tenth members -
FIGS. 5 and 6 show a pattern and an expanded view of one cell of an embodiment of the present invention which is specially adapted for a stent made of stainless steel. The pattern is similar to the pattern ofFIGS. 3 and 4 , and the same reference numerals are used to indicate the generally corresponding parts. The stents of the embodiment ofFIGS. 5 and 6 will normally be expanded by a balloon, in conventional fashion. - The embodiments of
FIGS. 3 and 5 can also be viewed as being made up of high frequency and low frequency vertical sinusoidal patterns or vertical loop containing sections which are arranged generally in the circumferential direction and which are periodically interconnected. Thus, there is a first loop containing section with loops occurring at a first frequency extending alongline 301 and a second loop containing section with also occurring at said first frequency extending alongline 302. A thirdloop containing section 303 extending alongline 305 has loops occurring at a second frequency that is higher than said first frequency. It is disposed between the first and second loop containing sections and alternately joined to the first and second loop containing sections. In the illustrated embodiment, the high frequency is in a ratio of 3/2 to the low frequency. As noted above, the higher frequency loop containing elements are smaller in width. The relative widths can be selected so that the high frequency elements are crimpable to the same diameter as the lower frequency elements. - Furthermore the high frequency vertical patterns of smaller width result in elements having a lower maximal strain. Specifically, the lower maximal strain is below the maximum strain without non-elastic deformation for the material of the stent. In this embodiment where the stent is made of stainless steel the lower maximal strain is below approximately 0.4%, even for a 1500 bend, as confirmed by finite element analysis. On the other hand, in a '303 type stent, for an equivalent amount of bending, exhibits a maximum strain of 8%. Thus, although the increased flexibility of the stent of the present invention means that, in addition to conforming better to the curved lumen, it will bend with each beat of the heart. The strain during heart beat happens 8,000,000 times every year and cannot be much above elastic limit without the stent breaking Since, embodiments of the present invention keep the strain below the limit means that the stent of the present invention can bend with the lumen as the heart beats, for many years without breaking.
- Also in this embodiment of the invention, for example, the
second loops 531 are made stronger by shortening the third andfourth members 507, 510. This helps assure that the second loops do not “flare out” during delivery of the stent through tortuous anatomy. This “flaring out” is not a concern with NiTi stents which are covered by a sheath during delivery. - Furthermore, the length of the members in this embodiment may be shorter than the length of the corresponding members in the embodiment illustrated in
FIGS. 3 and 4 . Typically, the amount of strain allowed in a self-expanding NiTi stent may be around 10%. In a stainless steel stent, the amount of strain allowed during the plastic deformation which take place, for example, during expansion, typically may be 20% or greater. Therefore, to facilitate stents made of NiTi and stents made of stainless steel expanding to comparable diameters, the members of the NiTi stent may be longer than the members of a stainless steel stent. - When the stent is within a curved lumen when it is expanded, the stent is curved as shown in
FIG. 2 The result of this curving, for asingle cell 500, is shown inFIG. 15 . The cells on the outside of the curve open in length, but narrow in width whereas the cells on the inside of the curve shorten in length but thicken in width. As a result, the density of the members per unit of surface area remains closer to what it is in an uncurved, expanded condition, both on the inside and outside of the curve. Similarly, as can be seen fromFIG. 15 , the area of the cell remains more constant than it would without compensation. This results in maintaining a more constant density of stent elements in contact with the lumen, irrespective of location on the inside or outside of a curved section. In turn, when the stent is coated with a medicine, a more even dose is applied to the inside wall of the lumen, avoiding the possibility that a toxic dose be supplied at one area while a less than effective dose is applied to another area. In some cases, the ratio between a toxic dose and an effective dose may be smaller than 10:1. - Specifically, it can be appreciated that, in cells on the outside of the curve at the connection points 542 and 538, the cell will open up increasing the length of the cell. In addition, at the junction points 535, 536, 537, 539, 540 and 542, the adjoining struts will come closer to each other, to cause the cell to become narrower in width, or in the circumferential direction, compensating for the increase in length. On the inside of the curve, the longitudinal distances must decrease. Again, it is easy to see that the compression which occurs on the inside results in the struts on either side of the
junction points -
FIG. 7 illustrates another aspect of the present invention. The stent ofFIG. 7 is also constructed fromorthogonal meander patterns cells cell 50 is taught by U.S. Pat. No. 5,733,303. These cells are arranged so that they form alternatingbands 704 of first type ofcells 50 andbands 706 of the second type ofcells 700. - As seen in
FIG. 8 and particularly with respect to the cell labeled for ease of description, each of the '303cells 50 has a firstlongitudinal apex 100 and a secondlongitudinal end 78. Eachcell 50 also is provided with a firstlongitudinal end 77 and a secondlongitudinal apex 104 disposed at the secondlongitudinal end 78. Eachcell 50 also includes afirst member 51 having a longitudinal component having a first end 52 and asecond end 53; asecond member 54 having a longitudinal component having afirst end 55 and asecond end 56; athird member 57 having a longitudinal component having afirst end 58 and asecond end 59; and afourth member 60 having a longitudinal component having afirst end 61 and asecond end 62. The stent also includes a first loop orcurved member 63 defining afirst angle 64 disposed between the first end 52 of thefirst member 51 and thefirst end 55 of thesecond member 54. A second loop orcurved member 65 defining asecond angle 66 is disposed between thesecond end 59 of thethird member 57 and thesecond end 62 of thefourth member 60 and is disposed generally opposite to thefirst loop 63. A first flexible compensating member (or a section of a longitudinal meander pattern) 67 having curved portion and two legs with afirst end 68 and a second end 69 is disposed between thefirst member 51 and thethird member 57 with thefirst end 68 of the first flexible compensatingmember 67 joined to and communicating with thesecond end 53 of thefirst member 51 and the second end 69 of the first flexible compensatingmember 67 joined to and communicating with thefirst end 58 of thethird member 57. Thefirst end 68 and the second end 69 are disposed a variable longitudinal distance 70 from each other. A second flexible compensating member (or, a section of a longitudinal meander pattern) 71 having afirst end 72 and a second end 73 is disposed between thesecond member 54 and thefourth member 60. Thefirst end 72 of the second flexible compensatingmember 71 is joined to and communicates with thesecond end 56 of thesecond member 54 and the second end 73 of the second flexible compensatingmember 71 is joined to and communicates with thefirst end 61 of thefourth member 60. Thefirst end 72 and the second end 73 are disposed a variable longitudinal distance 74 from each other. In this embodiment, the first and second flexible compensating members, and particularly the curved portion thereof, 67 and 71 are arcuate. - When curved stent is expanded while inside a lumen, also in the case of the
cells 50, cells on the outside of the curve open in length, but narrow in width whereas the cells on the inside of the curve shorten in length but thicken in width to provide a density of the members per unit of surface area that remains more constant between the inside and outside of the curve. - Specifically, it can be appreciated that, in cells on the outside of the curve the flexible connecting
members members members flexible connector members loops members members members - The second type of
cell 700 is illustrated inFIG. 9 and the same reference numerals are used to indicate generally corresponding areas of the cell. Theapices cell 700 are offset circumferentially. Also, each flexible compensatingmember leg 79 with afirst end 80 and asecond end 81; a second portion orleg 82 with afirst end 83 and asecond end 84; and a third portion orleg 85 with thefirst end 86 and asecond end 87, with thesecond end 81 and thesecond end 84 being joined by a curved member and thefirst end 83 and thefirst end 86 being joined by a curved member. The first end of a flexible compensatingmember first end 80 of thefirst portion 79, and the second end of a flexible compensatingmember second end 87 of thethird portion 85. A first area ofinflection 88 is disposed between thesecond end 81 of thefirst portion 79 and thesecond end 84 of thesecond portion 82 where the curved portion joining them lies. A second area ofinflection 89 is disposed between thefirst end 83 of thesecond portion 82 and thefirst end 86 of thethird portion 85 where the curved portion joining them lies. - While
FIG. 7 illustrates a pattern of alternating bands of cells, the stent may be optimized for a particular usage by tailoring the configuration of the bands. For example, the middle band of the second type ofcells 700 may instead be formed ofcells 50, or vice versa. The second type of cells inFIG. 7 may also utilize the cell configurations described with respect toFIGS. 4 and 6 . The cell configurations ofFIGS. 4 and 6 provide the advantage that they will not cause any torque of one portion of the cell relative to another portion of the cell about the longitudinal axis of the stent upon expansion, which may happen when the second type ofcells 700 expand, a torque which could cause a stent to deform, and stick out. - As illustrated in
FIG. 7 , all of the flexible compensating members are arranged so that the path of the flexible compensating members, from left to right, travels in a generally downward direction. Thecells 700 can also be arranged so that the flexible compensating members in one band are arranged in a generally upward direction, and the flexible compensating members in an adjacent band are arranged in a generally downward direction. One skilled in the art can easily make these modifications. -
FIG. 10 is a schematic representation comparing thecells 804 of the present invention, which have three points where the intertwined first and second meander patterns meet and are in that sense three cornered or triangular cells, withcells 802 of the '303 stent which have four points where the intertwined first and second meander patterns meet and are in that sense four cornered or square cells. More particularly, on the left side ofFIG. 10 , a pair ofvertical meander patterns members triangular cells 804. By triangular cell, it is meant. that there are threesections points - On the right side of
FIG. 10 , a pair ofvertical meander patterns members square cells 804. By square cell, it is meant that there are four sections, each having loop portions, and four associated points of their joining, forming each cell. For example, theshaded cell 802 is formed from foursections - Both the square cell and the triangular cell have two kinds of sections with loops. The first kind of loop containing section is formed from a vertical meander pattern and is optimized predominantly to enable radial support. The second kind of loop containing section is optimized predominantly to enable flexibility along the longitudinal axis of the stent. Although each loop containing section is optimized predominantly to enable a desired characteristic of the stent, the sections are interconnected and cooperate to define the characteristics of the stent. Therefore, the first kind of loop containing section contributes to the longitudinal flexibility of the stent, and the second kind of loop containing section contributes to the radial support of the stent.
- In the
square cell 802, it can be seen that the second kind ofloop containing sections inflection point loop containing sections inflection point areas - Furthermore, it can be seen that a
square cell 802 is generally more elongated along the longitudinal axis of the stent than atriangular cell 804, which is generally more elongated along the circumference of the stent. This also contributes to higher flexibility after expansion. - If the
first meander patterns triangular cell 804 is the same as asquare cell 802. This can be more readily understood with reference to a band of cells around the circumference of a stent. Each band will encompass the same area, and each band will have the same number of cells. Accordingly, the area of each cell in one band formed of square cells will be the same as the area of each cell in another band formed of triangular cells. - Although the areas of the cells are equal, the perimeter of the triangular cell is larger than the perimeter of the square cell. Therefore, in comparison to a square cell, a triangular cell offers increased coverage of a vessel wall.
- In the particular embodiments described above, the stent is substantially uniform over its entire length. However, other applications where portions of the stent are adapted to provide different characteristics are also possible. For example, as shown in
FIG. 11 , a band ofcells 850 may be designed to provide different flexibility characteristics or different radial compression characteristics than the remaining bands of cells by altering the widths and lengths of the members making up that band. Or, the stent may be adapted to provide increased access to a side branch lumen by providing at least onecell 852 which is larger in size then the remaining cells, or by providing an entire band ofcells 854 which are larger in size than the other bands of cells. Or, the stent may be designed to expand to different diameters along the length of the stent. The stent may also be treated after formation of the stent by coating the stent with a medicine, plating the stent with a protective material, plating the stent with a radiopaque material, or covering the stent with a material. -
FIGS. 12 and 13 show alternative patterns for a stent constructed according to the principles of the present invention. The stent shown inFIG. 12 has two bands ofcells 856 located at each of the proximal end 860 and distal and 862. The cells that form the bands ofcells 856 located at the ends of the stent are '303 type cells. The remaining cells in the stent are the same as described with respect to thecells 500 depicted inFIG. 6 . The stent shown inFIG. 13 has alternating bands of cells 864, 866, 868. The first type of band of cells 864 is composed of '303 type cells. The second and third types of bands of cells 866, 868 are formed of the cells described with respect to thecells 500 depicted inFIG. 4 . Of course, any various combination of cells may be used in the present invention. - Thus, what is described is a longitudinally flexible stent that utilizes a closed cell structure to provide excellent coverage of the vessel wall. The general concepts described herein can be utilized to form stents with different configurations than the particular embodiments described herein. For example, the general concepts can be used to form bifurcated stents. It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described above. Rather, the scope of the present invention is defined by the claims which follow.
Claims (10)
1-41. (canceled)
42. A stent having a longitudinal axis along the length of the stent comprising:
a. a first loop containing section consisting of a single, continuous, generally sinusoidal pattern of loops around the entire circumference of the stent, said first loop containing section having an axis orthogonal to the longitudinal axis of the stent, the loops in said first loop containing section occurring at a first frequency;
b. a second loop containing section consisting of a single, continuous, generally sinusoidal pattern of loops around the entire circumference of the stent, said second loop containing section having an axis orthogonal to the longitudinal axis of the stent, the loops in said second loop containing section also occurring at said first frequency;
c. said first and second loop containing sections alternating for at least two consecutive repetitions along the longitudinal axis of the stent; and
d. a third loop containing section consisting of a single, continuous, generally sinusoidal pattern, said third loop containing section having an axis orthogonal to the longitudinal axis of the stent, the loops in said third loop containing section occurring at a second frequency that is higher than said first frequency, said third loop containing section disposed in the general circumferential space between each adjacent first and second loop containing sections, said third loop containing sections joining to said first and second loop containing sections directly without any intervening material to form a uniform pattern of flexible cells; and
e. the loops of the first, second, and third loop containing sections further include struts having a thickness in the radial direction and width in the circumferential direction, wherein the struts of the first and second loop containing sections are wider than the width of the struts of the third loop containing section.
43. The stent according to claim 42 , wherein said stent is coated with a medicine.
44. The stent according to claim 42 , wherein the first, second and third loop containing sections are disposed and adapted to cooperate so that, when the expanded stent is in a curved lumen, cells on the outside of the curve open in length but narrow circumferentially, whereas cells on the inside of the curve shorten in length but widen circumferentially.
45. A stent consisting essentially of a plurality of triangular cells, each triangular cell consisting essentially of three loop containing sections:
a. a first loop containing section, the first loop containing section having loops, said loops occurring at a first frequency, said loop containing section having a first end and a second end;
b. a second loop containing section having loops, said loops occurring at said first frequency, said second loop containing section having a first end and a second end; and
c. a third loop containing section having loops, said loops occurring at a second frequency lower than the first frequency, said third loop containing section having a first end and a second end;
d. wherein the first end of the first loop containing section is joined to the second end of the second loop containing section, the first end of the second loop containing section is joined to the second end of the third loop containing section, and the first end of the third loop containing section is joined to the second end of the first loop containing section;
e. wherein the first, second and third loop containing sections further include struts having a thickness in the radial direction and width in the circumferential direction, wherein the struts of the third loop containing section are wider than the width of the struts of the first and second loop containing sections.
46. The stent according to claim 45 , wherein said stent is coated with a medicine.
47. An expandable coronary stent consisting essentially of a pattern of uniform cells, each of the cells consisting essentially of a plurality of substantially straight members consisting of:
a. a first member having a first end and a second end;
b. a second member having a first end and a second end;
c. a third member having a first end and a second end;
d. a fourth member having a first end and a second end; the first end of the first member communicating with the first end of the second member, the second end of the second member communicating with the second end of the third member, and the first end of the third member communicating with the first end of the fourth member;
e. the first member and the second member with the curved portion at their first ends forming a first loop;
f. the third member and the fourth member with the curved portion at their first ends forming a second loop, the first, second, third and fourth members forming a portion of a first circumferential band formed of a single, continuous, generally sinusoidal pattern of loops;
g. a fifth member having a first end and a second end;
h. a sixth member having a first end and a second end;
i. a seventh member having a first end and a second end;
j. an eighth member having a first end and a second end;
k. a ninth member having a first end and a second end; and
l. a tenth member having a first end and a second end, the first end of the fifth member communicating with the second end of the first member, the second end of the fifth member communicating with the second end of the sixth member, the first end of the sixth member communicating with the first end of the seventh member, the second end of the seventh member communicating with the second end of the eighth member, the first end of the eighth member communicating with the first end of the ninth member, the second end of the ninth member communicating with the second end of the tenth member, and the first end of the tenth member communicating with the second end of the fourth member;
m. the fifth member and the sixth member with the curved portion at their ends forming a third loop;
n. the seventh member and the eighth member with the curved portion at their ends forming a fourth loop; and
o. the ninth member and the tenth member with the curved portion at their ends forming a fifth loop, said fifth, sixth, seventh, eighth, ninth and tenth members forming a portion of a second circumferential band formed of a single, continuous, generally sinusoidal pattern of loops disposed in the general circumferential space between each of the first circumferential bands to form a pattern that repeats at least two consecutive repetitions along the longitudinal axis of the stent, wherein each first and each second circumferential band is a single, continuous generally sinusoidal pattern extending in the circumferential direction and the first, second, third, fourth, fifth, sixth, seventh, eighth, ninth, and tenth members form a uniform pattern of flexible cells; and
p. the first, second, third and fourth members having a thickness in the radial direction and width in the circumferential direction, wherein the first, second, third and fourth members are wider than the width of the fifth, sixth, seventh, eighth, ninth and tenth members.
48. The stent according to claim 47 , wherein said stent is coated with a medicine.
49. A coronary stent having a longitudinal axis along the length of the stent consisting essentially of in both the unexpanded and expanded state:
a. a first loop containing section, said first loop containing section having an axis perpendicular to the longitudinal axis of the stent, the loops in said first loop containing section occurring at a first frequency;
b. a second loop containing section, said second loop containing section having an axis perpendicular to the longitudinal axis of the stent, the loops in said second loop containing section also occurring at said first frequency, said second loop containing section being 180° out of phase with said first loop containing section along the longitudinal axis of the stent;
c. at least one of said first and second loop containing sections consisting of a single, continuous, generally sinusoidal pattern; and
d. a third loop containing section, said third loop containing section formed of a single, continuous, generally sinusoidal pattern extending in a continuous band of loops around the entire circumference of the stent, the loops in said third loop containing section occurring at a second frequency that is higher than said first frequency, said loops in said third loop containing section having an axis parallel to the axis of the first and second loop containing sections, said third loop containing section disposed in the general circumferential space between each of said first and second loop containing sections to form consecutively repeating patterns along the longitudinal axis of the stent for at least two repetitions, said first, second and third loop containing sections connected at junction points to form a pattern of uniform cells; and
e. the loops of the first, second, and third loop containing sections further include struts having a thickness in the radial direction and width in the circumferential direction, wherein the struts of the first and second loop containing sections are wider than the struts of the third loop containing section.
50. The stent according to claim 49 , wherein said stent is coated with a medicine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/644,688 US20100100166A1 (en) | 2000-03-01 | 2009-12-22 | Longitudinally flexible stent |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/516,753 US7141062B1 (en) | 2000-03-01 | 2000-03-01 | Longitudinally flexible stent |
US20272300P | 2000-05-08 | 2000-05-08 | |
US09/795,794 US6709453B2 (en) | 2000-03-01 | 2001-02-28 | Longitudinally flexible stent |
US09/864,389 US7828835B2 (en) | 2000-03-01 | 2001-05-25 | Longitudinally flexible stent |
US12/644,688 US20100100166A1 (en) | 2000-03-01 | 2009-12-22 | Longitudinally flexible stent |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/864,389 Continuation US7828835B2 (en) | 2000-03-01 | 2001-05-25 | Longitudinally flexible stent |
Publications (1)
Publication Number | Publication Date |
---|---|
US20100100166A1 true US20100100166A1 (en) | 2010-04-22 |
Family
ID=25343166
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/864,389 Expired - Fee Related US7828835B2 (en) | 2000-03-01 | 2001-05-25 | Longitudinally flexible stent |
US12/644,688 Abandoned US20100100166A1 (en) | 2000-03-01 | 2009-12-22 | Longitudinally flexible stent |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/864,389 Expired - Fee Related US7828835B2 (en) | 2000-03-01 | 2001-05-25 | Longitudinally flexible stent |
Country Status (7)
Country | Link |
---|---|
US (2) | US7828835B2 (en) |
EP (2) | EP1304090A3 (en) |
JP (1) | JP2005503843A (en) |
AR (1) | AR033925A1 (en) |
CA (1) | CA2439081A1 (en) |
DE (1) | DE10153340A1 (en) |
WO (1) | WO2002094127A2 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070077347A1 (en) * | 1996-12-26 | 2007-04-05 | Jacob Richter | Flat process of drug coating for stents |
US20070233235A1 (en) * | 2002-10-09 | 2007-10-04 | Boston Scientific Scimed, Inc. | Stent with Improved Flexibility |
US20110238152A1 (en) * | 2006-03-15 | 2011-09-29 | Medinol Ltd. | Flat process of preparing drug eluting stents |
US8512395B2 (en) | 2010-12-30 | 2013-08-20 | Boston Scientific Scimed, Inc. | Stent with horseshoe shaped bridges |
US8663313B2 (en) | 2011-03-03 | 2014-03-04 | Boston Scientific Scimed, Inc. | Low strain high strength stent |
US8790388B2 (en) | 2011-03-03 | 2014-07-29 | Boston Scientific Scimed, Inc. | Stent with reduced profile |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7204848B1 (en) | 1995-03-01 | 2007-04-17 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
US6896696B2 (en) * | 1998-11-20 | 2005-05-24 | Scimed Life Systems, Inc. | Flexible and expandable stent |
US6241762B1 (en) * | 1998-03-30 | 2001-06-05 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
US20040254635A1 (en) * | 1998-03-30 | 2004-12-16 | Shanley John F. | Expandable medical device for delivery of beneficial agent |
US7208010B2 (en) * | 2000-10-16 | 2007-04-24 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
US6755856B2 (en) | 1998-09-05 | 2004-06-29 | Abbott Laboratories Vascular Enterprises Limited | Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation |
US6293967B1 (en) | 1998-10-29 | 2001-09-25 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
US6290673B1 (en) * | 1999-05-20 | 2001-09-18 | Conor Medsystems, Inc. | Expandable medical device delivery system and method |
US8920487B1 (en) | 2000-03-01 | 2014-12-30 | Medinol Ltd. | Longitudinally flexible stent |
US7758627B2 (en) * | 2000-03-01 | 2010-07-20 | Medinol, Ltd. | Longitudinally flexible stent |
US8496699B2 (en) | 2000-03-01 | 2013-07-30 | Medinol Ltd. | Longitudinally flexible stent |
US8202312B2 (en) | 2000-03-01 | 2012-06-19 | Medinol Ltd. | Longitudinally flexible stent |
US7141062B1 (en) | 2000-03-01 | 2006-11-28 | Medinol, Ltd. | Longitudinally flexible stent |
US6764507B2 (en) | 2000-10-16 | 2004-07-20 | Conor Medsystems, Inc. | Expandable medical device with improved spatial distribution |
DE60112318D1 (en) | 2000-10-16 | 2005-09-01 | Conor Medsystems Inc | EXPANDABLE MEDICAL DEVICE FOR DELIVERING A REMEDY |
US20040073294A1 (en) * | 2002-09-20 | 2004-04-15 | Conor Medsystems, Inc. | Method and apparatus for loading a beneficial agent into an expandable medical device |
US6964680B2 (en) * | 2001-02-05 | 2005-11-15 | Conor Medsystems, Inc. | Expandable medical device with tapered hinge |
US7842083B2 (en) * | 2001-08-20 | 2010-11-30 | Innovational Holdings, Llc. | Expandable medical device with improved spatial distribution |
EP1507494A2 (en) * | 2002-05-06 | 2005-02-23 | Abbott Laboratories | Endoprosthesis for controlled contraction and expansion |
EP1503700B1 (en) * | 2002-05-08 | 2012-09-26 | Abbott Laboratories | Endoprosthesis having foot extensions |
US20040054398A1 (en) * | 2002-09-13 | 2004-03-18 | Cully Edward H. | Stent device with multiple helix construction |
US20040127976A1 (en) * | 2002-09-20 | 2004-07-01 | Conor Medsystems, Inc. | Method and apparatus for loading a beneficial agent into an expandable medical device |
US7331986B2 (en) * | 2002-10-09 | 2008-02-19 | Boston Scientific Scimed, Inc. | Intraluminal medical device having improved visibility |
ATE526038T1 (en) * | 2003-03-28 | 2011-10-15 | Innovational Holdings Llc | IMPLANTABLE MEDICAL DEVICE WITH CONTINUOUS MEDIUM CONCENTRATION DISTANCE |
US7625398B2 (en) * | 2003-05-06 | 2009-12-01 | Abbott Laboratories | Endoprosthesis having foot extensions |
US7625401B2 (en) * | 2003-05-06 | 2009-12-01 | Abbott Laboratories | Endoprosthesis having foot extensions |
US7169179B2 (en) * | 2003-06-05 | 2007-01-30 | Conor Medsystems, Inc. | Drug delivery device and method for bi-directional drug delivery |
US7785653B2 (en) * | 2003-09-22 | 2010-08-31 | Innovational Holdings Llc | Method and apparatus for loading a beneficial agent into an expandable medical device |
US20050182474A1 (en) * | 2004-02-13 | 2005-08-18 | Medtronic Vascular, Inc. | Coated stent having protruding crowns and elongated struts |
JP4908743B2 (en) * | 2004-06-08 | 2012-04-04 | テルモ株式会社 | In vivo indwelling stent and biological organ dilator |
DE102004045226B4 (en) | 2004-09-17 | 2008-01-17 | Optiray Medizintechnik Gmbh | support prosthesis |
ES2764992T3 (en) | 2005-04-04 | 2020-06-05 | Flexible Stenting Solutions Inc | Flexible stent |
US20060248698A1 (en) * | 2005-05-05 | 2006-11-09 | Hanson Brian J | Tubular stent and methods of making the same |
WO2007005800A1 (en) | 2005-06-30 | 2007-01-11 | Abbott Laboratories | Endoprosthesis having foot extensions |
US8414637B2 (en) * | 2006-09-08 | 2013-04-09 | Boston Scientific Scimed, Inc. | Stent |
US7810223B2 (en) * | 2007-05-16 | 2010-10-12 | Boston Scientific Scimed, Inc. | Method of attaching radiopaque markers to intraluminal medical devices, and devices formed using the same |
US8128679B2 (en) | 2007-05-23 | 2012-03-06 | Abbott Laboratories Vascular Enterprises Limited | Flexible stent with torque-absorbing connectors |
US8016874B2 (en) | 2007-05-23 | 2011-09-13 | Abbott Laboratories Vascular Enterprises Limited | Flexible stent with elevated scaffolding properties |
US7988723B2 (en) | 2007-08-02 | 2011-08-02 | Flexible Stenting Solutions, Inc. | Flexible stent |
US8920488B2 (en) | 2007-12-20 | 2014-12-30 | Abbott Laboratories Vascular Enterprises Limited | Endoprosthesis having a stable architecture |
US9149376B2 (en) | 2008-10-06 | 2015-10-06 | Cordis Corporation | Reconstrainable stent delivery system |
CN104188742B (en) * | 2009-04-10 | 2018-01-19 | 泰科保健集团有限合伙公司 | Implant with high antifatigue, implant induction system and application method |
US8366765B2 (en) * | 2009-09-18 | 2013-02-05 | Medtronic Vascular, Inc. | Helical stent with connections |
JP2011115634A (en) * | 2011-03-16 | 2011-06-16 | Terumo Corp | Indwelling stent and biological organ dilator |
GB201106757D0 (en) * | 2011-04-20 | 2011-06-01 | Arterius Ltd | A stent |
US20140285335A1 (en) * | 2013-03-15 | 2014-09-25 | Alfred M. Haas | Spc |
JP5695259B1 (en) | 2014-02-19 | 2015-04-01 | 株式会社World Medish | High flexibility stent |
EP3160525B1 (en) | 2014-06-27 | 2023-08-09 | Boston Scientific Scimed, Inc. | Compositions, devices, kits and methods for attaching stent-containing medical devices to tissue |
DE102015120142A1 (en) * | 2015-11-20 | 2017-05-24 | Biotronik Se & Co. Kg | Stent with flexible edge segment |
Citations (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5183180A (en) * | 1990-12-03 | 1993-02-02 | Otto Industries, Inc. | Plastic refuse container |
US5231598A (en) * | 1991-09-30 | 1993-07-27 | National Semiconductor Corporation | Direct digital synthesis measurement signal skew tester |
US5591224A (en) * | 1992-03-19 | 1997-01-07 | Medtronic, Inc. | Bioelastomeric stent |
US5603721A (en) * | 1991-10-28 | 1997-02-18 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
US5695516A (en) * | 1996-02-21 | 1997-12-09 | Iso Stent, Inc. | Longitudinally elongating balloon expandable stent |
US5697971A (en) * | 1996-06-11 | 1997-12-16 | Fischell; Robert E. | Multi-cell stent with cells having differing characteristics |
US5707386A (en) * | 1993-02-04 | 1998-01-13 | Angiomed Gmbh & Company Medizintechnik Kg | Stent and method of making a stent |
US5800508A (en) * | 1994-02-09 | 1998-09-01 | Boston Scientific Technology, Inc. | Bifurcated endoluminal prosthesis |
US5807404A (en) * | 1996-09-19 | 1998-09-15 | Medinol Ltd. | Stent with variable features to optimize support and method of making such stent |
US5827321A (en) * | 1997-02-07 | 1998-10-27 | Cornerstone Devices, Inc. | Non-Foreshortening intraluminal prosthesis |
US5837313A (en) * | 1995-04-19 | 1998-11-17 | Schneider (Usa) Inc | Drug release stent coating process |
US5843181A (en) * | 1994-04-18 | 1998-12-01 | Hancock Jaffe Laboratories | Biological material pre-fixation treatment |
US5843101A (en) * | 1997-05-02 | 1998-12-01 | Fry; William R. | Disposable clip for temporary vessel occulsion |
US5913895A (en) * | 1997-06-02 | 1999-06-22 | Isostent, Inc. | Intravascular stent with enhanced rigidity strut members |
US6120847A (en) * | 1999-01-08 | 2000-09-19 | Scimed Life Systems, Inc. | Surface treatment method for stent coating |
US6132461A (en) * | 1998-03-27 | 2000-10-17 | Intratherapeutics, Inc. | Stent with dual support structure |
US6159237A (en) * | 1996-02-14 | 2000-12-12 | Inflow Dynamics, Inc. | Implantable vascular and endoluminal stents |
US6162245A (en) * | 1997-05-07 | 2000-12-19 | Iowa-India Investments Company Limited | Stent valve and stent graft |
US6179868B1 (en) * | 1998-03-27 | 2001-01-30 | Janet Burpee | Stent with reduced shortening |
US6183353B1 (en) * | 1997-06-06 | 2001-02-06 | Cook Incorporated | Apparatus for polishing surgical stents |
US6190403B1 (en) * | 1998-11-13 | 2001-02-20 | Cordis Corporation | Low profile radiopaque stent with increased longitudinal flexibility and radial rigidity |
US6193747B1 (en) * | 1997-02-17 | 2001-02-27 | Jomed Implantate Gmbh | Stent |
US6197048B1 (en) * | 1996-12-26 | 2001-03-06 | Medinol Ltd. | Stent |
US6251134B1 (en) * | 1999-02-28 | 2001-06-26 | Inflow Dynamics Inc. | Stent with high longitudinal flexibility |
US6299604B1 (en) * | 1998-08-20 | 2001-10-09 | Cook Incorporated | Coated implantable medical device |
US6416539B1 (en) * | 1997-06-30 | 2002-07-09 | Medex, Inc. | Controlled length intraluminal implant |
US6471980B2 (en) * | 2000-12-22 | 2002-10-29 | Avantec Vascular Corporation | Intravascular delivery of mycophenolic acid |
US6478815B1 (en) * | 2000-09-18 | 2002-11-12 | Inflow Dynamics Inc. | Vascular and endoluminal stents |
US6540775B1 (en) * | 2000-06-30 | 2003-04-01 | Cordis Corporation | Ultraflexible open cell stent |
US6569180B1 (en) * | 2000-06-02 | 2003-05-27 | Avantec Vascular Corporation | Catheter having exchangeable balloon |
US6602282B1 (en) * | 2000-05-04 | 2003-08-05 | Avantec Vascular Corporation | Flexible stent structure |
US6602281B1 (en) * | 1995-06-05 | 2003-08-05 | Avantec Vascular Corporation | Radially expansible vessel scaffold having beams and expansion joints |
US6648911B1 (en) * | 2000-11-20 | 2003-11-18 | Avantec Vascular Corporation | Method and device for the treatment of vulnerable tissue site |
US6652573B2 (en) * | 1998-05-16 | 2003-11-25 | Jomed Gmbh | Radial expansible stent for implanting in body vessels |
US6776793B2 (en) * | 1995-03-01 | 2004-08-17 | Scimed Life Systems, Inc. | Longitudinally flexible expandable stent |
US6790227B2 (en) * | 2001-03-01 | 2004-09-14 | Cordis Corporation | Flexible stent |
US20050273157A1 (en) * | 2004-06-08 | 2005-12-08 | Gregory Pinchasik | Stent having struts with reverse direction curvature |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5037377A (en) | 1984-11-28 | 1991-08-06 | Medtronic, Inc. | Means for improving biocompatibility of implants, particularly of vascular grafts |
US4755593A (en) | 1985-07-24 | 1988-07-05 | Lauren Mark D | Novel biomaterial of cross-linked peritoneal tissue |
US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4886062A (en) | 1987-10-19 | 1989-12-12 | Medtronic, Inc. | Intravascular radially expandable stent and method of implant |
US5133732A (en) | 1987-10-19 | 1992-07-28 | Medtronic, Inc. | Intravascular stent |
US5571166A (en) | 1992-03-19 | 1996-11-05 | Medtronic, Inc. | Method of making an intraluminal stent |
US5510077A (en) | 1992-03-19 | 1996-04-23 | Dinh; Thomas Q. | Method of making an intraluminal stent |
DE69326631T2 (en) | 1992-03-19 | 2000-06-08 | Medtronic Inc | Intraluminal expansion device |
BE1006440A3 (en) | 1992-12-21 | 1994-08-30 | Dereume Jean Pierre Georges Em | Luminal endoprosthesis AND METHOD OF PREPARATION. |
US5464650A (en) | 1993-04-26 | 1995-11-07 | Medtronic, Inc. | Intravascular stent and method |
US5733303A (en) | 1994-03-17 | 1998-03-31 | Medinol Ltd. | Flexible expandable stent |
US5693085A (en) | 1994-04-29 | 1997-12-02 | Scimed Life Systems, Inc. | Stent with collagen |
DE4418336A1 (en) | 1994-05-26 | 1995-11-30 | Angiomed Ag | Stent for widening and holding open receptacles |
US5836964A (en) | 1996-10-30 | 1998-11-17 | Medinol Ltd. | Stent fabrication method |
CA2301351C (en) | 1994-11-28 | 2002-01-22 | Advanced Cardiovascular Systems, Inc. | Method and apparatus for direct laser cutting of metal stents |
US5575818A (en) | 1995-02-14 | 1996-11-19 | Corvita Corporation | Endovascular stent with locking ring |
US6896696B2 (en) | 1998-11-20 | 2005-05-24 | Scimed Life Systems, Inc. | Flexible and expandable stent |
ATE220308T1 (en) | 1995-03-01 | 2002-07-15 | Scimed Life Systems Inc | LONGITUDONLY FLEXIBLE AND EXPANDABLE STENT |
DE19512066A1 (en) | 1995-04-01 | 1996-11-28 | Variomed Ag | Stent for transluminal implantation e.g. blood vessels |
CZ292021B6 (en) | 1995-04-26 | 2003-07-16 | Medinol Ltd. | Connector for connecting adjacent areas of adjacent segments of an articulated stent and the articulated stent per se |
DE19530835A1 (en) | 1995-08-22 | 1997-02-27 | Emitec Emissionstechnologie | Process for producing a honeycomb body using sheet metal with solder material built up in layers |
US5865723A (en) | 1995-12-29 | 1999-02-02 | Ramus Medical Technologies | Method and apparatus for forming vascular prostheses |
US5713949A (en) | 1996-08-06 | 1998-02-03 | Jayaraman; Swaminathan | Microporous covered stents and method of coating |
US5922021A (en) | 1996-04-26 | 1999-07-13 | Jang; G. David | Intravascular stent |
FR2758253B1 (en) | 1997-01-10 | 1999-04-02 | Nycomed Lab Sa | IMPLANTABLE DEVICE FOR THE TREATMENT OF A BODY DUCT |
US5855597A (en) | 1997-05-07 | 1999-01-05 | Iowa-India Investments Co. Limited | Stent valve and stent graft for percutaneous surgery |
DE29708879U1 (en) | 1997-05-20 | 1997-07-31 | Jomed Implantate Gmbh | Coronary stent |
US5855600A (en) | 1997-08-01 | 1999-01-05 | Inflow Dynamics Inc. | Flexible implantable stent with composite design |
US6165195A (en) | 1997-08-13 | 2000-12-26 | Advanced Cardiovascylar Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
DE69838256T2 (en) * | 1997-09-24 | 2008-05-15 | Med Institute, Inc., West Lafayette | RADIAL EXPANDABLE STENT |
US6013091A (en) | 1997-10-09 | 2000-01-11 | Scimed Life Systems, Inc. | Stent configurations |
NO311781B1 (en) | 1997-11-13 | 2002-01-28 | Medinol Ltd | Metal multilayer stents |
US5997973A (en) | 1997-11-18 | 1999-12-07 | Hughes Electronics Corporation | Articulating thermal membrane with integral hinges |
DE19753123B4 (en) | 1997-11-29 | 2006-11-09 | B. Braun Melsungen Ag | stent |
US6190406B1 (en) | 1998-01-09 | 2001-02-20 | Nitinal Development Corporation | Intravascular stent having tapered struts |
US6241762B1 (en) | 1998-03-30 | 2001-06-05 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
DE19829702C1 (en) | 1998-07-03 | 2000-03-16 | Heraeus Gmbh W C | Radially expandable support device V |
WO2000030563A1 (en) * | 1998-11-20 | 2000-06-02 | Scimed Life Systems, Inc. | Longitudinally flexible expandable stent |
DE19900411A1 (en) | 1999-01-08 | 2000-07-13 | Lothar Sellin | Stent with tubular flexible body has wall consisting of curved ribs joined by connecting pieces |
EP1020166A1 (en) | 1999-01-12 | 2000-07-19 | Orbus Medical Technologies, Inc. | Expandable intraluminal endoprosthesis |
US6383213B2 (en) | 1999-10-05 | 2002-05-07 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US6409753B1 (en) | 1999-10-26 | 2002-06-25 | Scimed Life Systems, Inc. | Flexible stent |
US6428569B1 (en) | 1999-11-09 | 2002-08-06 | Scimed Life Systems Inc. | Micro structure stent configurations |
DE19957063A1 (en) | 1999-11-26 | 2001-08-02 | Franz Herbst | Stent and method for its manufacture |
US6387120B2 (en) | 1999-12-09 | 2002-05-14 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
SG86458A1 (en) | 2000-03-01 | 2002-02-19 | Medinol Ltd | Longitudinally flexible stent |
US7141062B1 (en) | 2000-03-01 | 2006-11-28 | Medinol, Ltd. | Longitudinally flexible stent |
US20020116049A1 (en) | 2000-09-22 | 2002-08-22 | Scimed Life Systems, Inc. | Stent |
US6740114B2 (en) | 2001-03-01 | 2004-05-25 | Cordis Corporation | Flexible stent |
US20020138136A1 (en) | 2001-03-23 | 2002-09-26 | Scimed Life Systems, Inc. | Medical device having radio-opacification and barrier layers |
DE20108764U1 (en) | 2001-05-25 | 2001-11-29 | Medinol Ltd | Stent |
DE20108765U1 (en) | 2001-05-25 | 2001-10-31 | Medinol Ltd | Longitudinally flexible stent |
-
2001
- 2001-05-25 US US09/864,389 patent/US7828835B2/en not_active Expired - Fee Related
- 2001-10-29 EP EP01125340A patent/EP1304090A3/en not_active Withdrawn
- 2001-10-29 DE DE10153340A patent/DE10153340A1/en not_active Ceased
-
2002
- 2002-05-21 WO PCT/IB2002/001743 patent/WO2002094127A2/en not_active Application Discontinuation
- 2002-05-21 EP EP02733008A patent/EP1463459A4/en not_active Withdrawn
- 2002-05-21 CA CA002439081A patent/CA2439081A1/en not_active Abandoned
- 2002-05-21 JP JP2002590851A patent/JP2005503843A/en active Pending
- 2002-05-23 AR ARP020101926A patent/AR033925A1/en not_active Application Discontinuation
-
2009
- 2009-12-22 US US12/644,688 patent/US20100100166A1/en not_active Abandoned
Patent Citations (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5183180A (en) * | 1990-12-03 | 1993-02-02 | Otto Industries, Inc. | Plastic refuse container |
US5231598A (en) * | 1991-09-30 | 1993-07-27 | National Semiconductor Corporation | Direct digital synthesis measurement signal skew tester |
US5603721A (en) * | 1991-10-28 | 1997-02-18 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
US5591224A (en) * | 1992-03-19 | 1997-01-07 | Medtronic, Inc. | Bioelastomeric stent |
US5707386A (en) * | 1993-02-04 | 1998-01-13 | Angiomed Gmbh & Company Medizintechnik Kg | Stent and method of making a stent |
US5860999A (en) * | 1993-02-04 | 1999-01-19 | Angiomed Gmbh & Co.Medizintechnik Kg | Stent and method of using same |
US5800508A (en) * | 1994-02-09 | 1998-09-01 | Boston Scientific Technology, Inc. | Bifurcated endoluminal prosthesis |
US5843181A (en) * | 1994-04-18 | 1998-12-01 | Hancock Jaffe Laboratories | Biological material pre-fixation treatment |
US6776793B2 (en) * | 1995-03-01 | 2004-08-17 | Scimed Life Systems, Inc. | Longitudinally flexible expandable stent |
US5837313A (en) * | 1995-04-19 | 1998-11-17 | Schneider (Usa) Inc | Drug release stent coating process |
US6605107B1 (en) * | 1995-06-05 | 2003-08-12 | Avantec Vascular Corporation | Radially expansible vessel scaffolds mounted over balloons |
US6602281B1 (en) * | 1995-06-05 | 2003-08-05 | Avantec Vascular Corporation | Radially expansible vessel scaffold having beams and expansion joints |
US6159237A (en) * | 1996-02-14 | 2000-12-12 | Inflow Dynamics, Inc. | Implantable vascular and endoluminal stents |
US5695516A (en) * | 1996-02-21 | 1997-12-09 | Iso Stent, Inc. | Longitudinally elongating balloon expandable stent |
US5697971A (en) * | 1996-06-11 | 1997-12-16 | Fischell; Robert E. | Multi-cell stent with cells having differing characteristics |
US5807404A (en) * | 1996-09-19 | 1998-09-15 | Medinol Ltd. | Stent with variable features to optimize support and method of making such stent |
US6197048B1 (en) * | 1996-12-26 | 2001-03-06 | Medinol Ltd. | Stent |
US5827321A (en) * | 1997-02-07 | 1998-10-27 | Cornerstone Devices, Inc. | Non-Foreshortening intraluminal prosthesis |
US6193747B1 (en) * | 1997-02-17 | 2001-02-27 | Jomed Implantate Gmbh | Stent |
US5843101A (en) * | 1997-05-02 | 1998-12-01 | Fry; William R. | Disposable clip for temporary vessel occulsion |
US6162245A (en) * | 1997-05-07 | 2000-12-19 | Iowa-India Investments Company Limited | Stent valve and stent graft |
US5913895A (en) * | 1997-06-02 | 1999-06-22 | Isostent, Inc. | Intravascular stent with enhanced rigidity strut members |
US6183353B1 (en) * | 1997-06-06 | 2001-02-06 | Cook Incorporated | Apparatus for polishing surgical stents |
US6416539B1 (en) * | 1997-06-30 | 2002-07-09 | Medex, Inc. | Controlled length intraluminal implant |
US20040088043A1 (en) * | 1997-10-03 | 2004-05-06 | Avantec Vascular Corporation | Radially expansible vessel scaffold having modified radiopacity |
US6179868B1 (en) * | 1998-03-27 | 2001-01-30 | Janet Burpee | Stent with reduced shortening |
US6132461A (en) * | 1998-03-27 | 2000-10-17 | Intratherapeutics, Inc. | Stent with dual support structure |
US6652573B2 (en) * | 1998-05-16 | 2003-11-25 | Jomed Gmbh | Radial expansible stent for implanting in body vessels |
US6299604B1 (en) * | 1998-08-20 | 2001-10-09 | Cook Incorporated | Coated implantable medical device |
US6190403B1 (en) * | 1998-11-13 | 2001-02-20 | Cordis Corporation | Low profile radiopaque stent with increased longitudinal flexibility and radial rigidity |
US6120847A (en) * | 1999-01-08 | 2000-09-19 | Scimed Life Systems, Inc. | Surface treatment method for stent coating |
US6251134B1 (en) * | 1999-02-28 | 2001-06-26 | Inflow Dynamics Inc. | Stent with high longitudinal flexibility |
US6602282B1 (en) * | 2000-05-04 | 2003-08-05 | Avantec Vascular Corporation | Flexible stent structure |
US6569180B1 (en) * | 2000-06-02 | 2003-05-27 | Avantec Vascular Corporation | Catheter having exchangeable balloon |
US6540775B1 (en) * | 2000-06-30 | 2003-04-01 | Cordis Corporation | Ultraflexible open cell stent |
US6478815B1 (en) * | 2000-09-18 | 2002-11-12 | Inflow Dynamics Inc. | Vascular and endoluminal stents |
US6648911B1 (en) * | 2000-11-20 | 2003-11-18 | Avantec Vascular Corporation | Method and device for the treatment of vulnerable tissue site |
US6471980B2 (en) * | 2000-12-22 | 2002-10-29 | Avantec Vascular Corporation | Intravascular delivery of mycophenolic acid |
US6790227B2 (en) * | 2001-03-01 | 2004-09-14 | Cordis Corporation | Flexible stent |
US20050273157A1 (en) * | 2004-06-08 | 2005-12-08 | Gregory Pinchasik | Stent having struts with reverse direction curvature |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070077347A1 (en) * | 1996-12-26 | 2007-04-05 | Jacob Richter | Flat process of drug coating for stents |
US7959664B2 (en) * | 1996-12-26 | 2011-06-14 | Medinol, Ltd. | Flat process of drug coating for stents |
US20070233235A1 (en) * | 2002-10-09 | 2007-10-04 | Boston Scientific Scimed, Inc. | Stent with Improved Flexibility |
US7842080B2 (en) * | 2002-10-09 | 2010-11-30 | Boston Scientific Scimed, Inc. | Stent with improved flexibility |
US20110238152A1 (en) * | 2006-03-15 | 2011-09-29 | Medinol Ltd. | Flat process of preparing drug eluting stents |
US8828077B2 (en) | 2006-03-15 | 2014-09-09 | Medinol Ltd. | Flat process of preparing drug eluting stents |
US8512395B2 (en) | 2010-12-30 | 2013-08-20 | Boston Scientific Scimed, Inc. | Stent with horseshoe shaped bridges |
US8663313B2 (en) | 2011-03-03 | 2014-03-04 | Boston Scientific Scimed, Inc. | Low strain high strength stent |
US8790388B2 (en) | 2011-03-03 | 2014-07-29 | Boston Scientific Scimed, Inc. | Stent with reduced profile |
Also Published As
Publication number | Publication date |
---|---|
EP1463459A4 (en) | 2005-04-27 |
EP1304090A2 (en) | 2003-04-23 |
EP1463459A2 (en) | 2004-10-06 |
CA2439081A1 (en) | 2002-11-28 |
US7828835B2 (en) | 2010-11-09 |
WO2002094127A3 (en) | 2004-07-22 |
EP1304090A3 (en) | 2004-01-14 |
WO2002094127A2 (en) | 2002-11-28 |
AR033925A1 (en) | 2004-01-07 |
DE10153340A1 (en) | 2002-11-28 |
JP2005503843A (en) | 2005-02-10 |
US20020022876A1 (en) | 2002-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7828835B2 (en) | Longitudinally flexible stent | |
US6709453B2 (en) | Longitudinally flexible stent | |
CA2439088C (en) | Longitudinally flexible stent | |
US7722658B2 (en) | Longitudinally flexible stent | |
AU2004315736C1 (en) | Longitudinally flexible stent | |
AU2002304381A1 (en) | Longitudinally flexible stent | |
US7621947B2 (en) | Longitudinally flexible stent | |
WO2003022172A2 (en) | Longitudinally flexible stent | |
US20080215133A1 (en) | Longitudinally flexible stent | |
US8496699B2 (en) | Longitudinally flexible stent | |
AU2002304380A1 (en) | Longitudinally flexible stent | |
AU2002330689A1 (en) | Longitudinally flexible stent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MEDINOL, LTD.,ISRAEL Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:RICHTER, JACOB;PINCHASIK, GREGORY;SIGNING DATES FROM 20010730 TO 20010803;REEL/FRAME:023689/0468 |
|
STCB | Information on status: application discontinuation |
Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION |